Annamaria Agnes1,2, Caterina Puccioni1, Domenico D'Ugo1,2, Antonio Gasbarrini1,2, Alberto Biondi3,4, Roberto Persiani1,2. 1. Università Cattolica del Sacro Cuore, Largo F. Vito n.1, 00168, Rome, Italy. 2. Dipartimento Di Scienze Mediche E Chirurgiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo A. Gemelli n. 8, 00168, Rome, Italy. 3. Università Cattolica del Sacro Cuore, Largo F. Vito n.1, 00168, Rome, Italy. biondi.alberto@gmail.com. 4. Dipartimento Di Scienze Mediche E Chirurgiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo A. Gemelli n. 8, 00168, Rome, Italy. biondi.alberto@gmail.com.
Abstract
BACKGROUND: The gut microbiota (GM) has been proposed as one of the main determinants of colorectal surgery complications and theorized as the "missing factor" that could explain still poorly understood complications. Herein, we investigate this theory and report the current evidence on the role of the GM in colorectal surgery. METHODS: We first present the findings associating the role of the GM with the physiological response to surgery. Second, the change in GM composition during and after surgery and its association with colorectal surgery complications (ileus, adhesions, surgical-site infections, anastomotic leak, and diversion colitis) are reviewed. Finally, we present the findings linking GM science to the application of the enhanced recovery after surgery (ERAS) protocol, for the use of oral antibiotics with mechanical bowel preparation and for the administration of probiotics/synbiotics. RESULTS: According to preclinical and translational evidence, the GM is capable of influencing colorectal surgery outcomes. Clinical evidence supports the application of an ERAS protocol and the preoperative administration of multistrain probiotics/synbiotics. GM manipulation with oral antibiotics with mechanical bowel preparation still has uncertain benefits in right-sided colic resection but is very promising for left-sided colic resection. CONCLUSIONS: The GM may be a determinant of colorectal surgery outcomes. There is an emerging need to implement translational research on the topic. Future clinical studies should clarify the composition of preoperative and postoperative GM and the impact of the GM on different colorectal surgery complications and should assess the validity of GM-targeted measures in effectively reducing complications for all colorectal surgery locations.
BACKGROUND: The gut microbiota (GM) has been proposed as one of the main determinants of colorectal surgery complications and theorized as the "missing factor" that could explain still poorly understood complications. Herein, we investigate this theory and report the current evidence on the role of the GM in colorectal surgery. METHODS: We first present the findings associating the role of the GM with the physiological response to surgery. Second, the change in GM composition during and after surgery and its association with colorectal surgery complications (ileus, adhesions, surgical-site infections, anastomotic leak, and diversion colitis) are reviewed. Finally, we present the findings linking GM science to the application of the enhanced recovery after surgery (ERAS) protocol, for the use of oral antibiotics with mechanical bowel preparation and for the administration of probiotics/synbiotics. RESULTS: According to preclinical and translational evidence, the GM is capable of influencing colorectal surgery outcomes. Clinical evidence supports the application of an ERAS protocol and the preoperative administration of multistrain probiotics/synbiotics. GM manipulation with oral antibiotics with mechanical bowel preparation still has uncertain benefits in right-sided colic resection but is very promising for left-sided colic resection. CONCLUSIONS: The GM may be a determinant of colorectal surgery outcomes. There is an emerging need to implement translational research on the topic. Future clinical studies should clarify the composition of preoperative and postoperative GM and the impact of the GM on different colorectal surgery complications and should assess the validity of GM-targeted measures in effectively reducing complications for all colorectal surgery locations.
Authors: Mohamed Abbas; Nadia Gaïa; Nicolas C Buchs; Vaihere Delaune; Myriam Girard; Diego O Andrey; Jeremy Meyer; Jacques Schrenzel; Frédéric Ris; Stephan Harbarth; Vladimir Lazarevic Journal: Gut Pathog Date: 2022-01-04 Impact factor: 4.181
Authors: Dagmar Schierova; Radka Roubalova; Martin Kolar; Zuzana Stehlikova; Filip Rob; Zuzana Jackova; Stepan Coufal; Tomas Thon; Martin Mihula; Martin Modrak; Miloslav Kverka; Lukas Bajer; Klara Kostovcikova; Pavel Drastich; Jana Hercogova; Michaela Novakova; Martin Vasatko; Milan Lukas; Helena Tlaskalova-Hogenova; Zuzana Jiraskova Zakostelska Journal: Cells Date: 2021-11-16 Impact factor: 6.600
Authors: David Schult; Sandra Reitmeier; Plamena Koyumdzhieva; Tobias Lahmer; Moritz Middelhoff; Johanna Erber; Jochen Schneider; Juliane Kager; Marina Frolova; Julia Horstmann; Lisa Fricke; Katja Steiger; Moritz Jesinghaus; Klaus-Peter Janssen; Ulrike Protzer; Klaus Neuhaus; Roland M Schmid; Dirk Haller; Michael Quante Journal: Gut Microbes Date: 2022 Jan-Dec